Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. / Bretzel, RG; Nuber, U; Landgraf, W; Owens, DR; Bradley, Clare; Linn, T.

In: The Lancet, Vol. 371, No. 9618, 29.03.2008, p. 1073-1084.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1073-1084
Number of pages12
JournalThe Lancet
Issue number9618
Publication statusPublished - 29 Mar 2008
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

ID: 791451